← Eichor
Condition: Naion Non Arteritic Ischemic Optic Neuropathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Naion Non Arteritic Ischemic Optic Neuropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy
Phase 3 · 18 location(s) · Dompé Farmaceutici S.p.A · NCT07453888Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION
Phase 1 · 2 location(s) · The Foundation for Orthopaedics and Regenerative Medicine · NCT05147701Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT07206238Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Co
Phase 1 · 4 location(s) · Life Biosciences Inc. · NCT07290244
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.